From left: Drs. Jeffrey Wolf, Rodney Taylor, Tomas Kara and Scott Strome with other ICRC staff meet in Brno, Czech Republic
Physicians at the University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) will collaborate with research scientists from the Czech Republic to find new ways to treat head and neck cancer through biomedical research and technology development.
Several UMGCC head and neck oncologists with particular expertise in the area of cancer immunology and cancer vaccines – Dr. Scott Strome, Dr. Rodney Taylor and Dr. Jeffrey Wolf – recently visited the Czech Republic’s International Clinical Research Center (ICRC) in Brno, Czech Republic, to initiate the joint scientific program.
“This new international clinical research center has the potential to tear down many of the barriers which exist in translational medicine, improving our understanding of disease, our ability to enhance patient care and our ability to better the education of the next generation of clinician-scientists,” said Dr. Strome, who leads the Tumor Immunology research program at UMGCC and is chairman of Otohinolaryngology-Head and Neck Surgery at the University of Maryland School of Medicine.
The ICRC in Brno opened in 2006 with $90 million in funding from the Czech government and the European Union (EU). It is planned as one of the largest centers for medical and biotech research in the EU.
The collaboration with University of Maryland oncologists will extend the ICRC’s international scientific outreach efforts in education, research and technology transfer. Researchers at the Brno center already are working with doctors at the Mayo Clinic in Rochester, Minnesota, on cardiovascular studies. In addition to the oncology initiative with the University of Maryland, they also plan partnerships in the areas of neurovascular disease, internal medicine and neurology.
Dr. Tomas Kara, head of the ICRC Brno project, visited the University of Maryland School of Medicine in late April to discuss plans for the scientific partnership. He calls the ICRC “science without borders.”
“No single country has enough talented people in any one field to address the challenges facing humankind,” noted Dr. Kara. “The ICRC seeks to break down barriers and connect the best people working in the field to advance medical scientific and biotech knowledge in an accelerated time frame.”